Yan Xu
- Molecular Biology
- Hematology top 2%
- Oncology top 10%
- Cancer Research top 10%
- Genetics top 5%
- Topics
- Multiple Myeloma Research and Treatments (66 papers)Protein Degradation and Inhibitors (26 papers)Chronic Lymphocytic Leukemia Research (23 papers)
- Cited by
- HematologyPhysiologyGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Yan Xu
93 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 563
- Hematology 478
- Oncology 436
- Cancer Research 235
- Genetics 171
Countries citing papers authored by Yan Xu
This map shows the geographic impact of Yan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xu more than expected).
Fields of papers citing papers by Yan Xu
This network shows the impact of papers produced by Yan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xu. The network helps show where Yan Xu may publish in the future.
Co-authorship network of co-authors of Yan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yan Xu. A scholar is included among the top collaborators of Yan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Xu. Yan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 17 | |
| 9 | 0 | |
| 10 | 17 | |
| 11 | 10 | |
| 12 | 8 | |
| 13 | 0 | |
| 14 | 1 | |
| 15 | 5 | |
| 16 | 1 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 3 | |
| 20 | 22 |
About Yan Xu
Yan Xu is a scholar working on Hematology, Genetics and Oncology, having authored 111 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (66 papers), Protein Degradation and Inhibitors (26 papers) and Chronic Lymphocytic Leukemia Research (23 papers). The work is most often cited by research in Hematology (478 citations), Physiology (88 citations) and Genetics (171 citations). Yan Xu has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Lugui Qiu, Mu Hao, Shuhui Deng, Dehui Zou, Gang An, Weiwei Sui, Chikao Morimoto, Junichi Kameoka, Martin Hegen and Toshiaki Tanaka. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.